Lagumbay, Nhur Khaleed .
HRN: 26-29-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/26/2025
02/01/2025
IV
375 Mg
Q6H
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes